Sugaya Ryo, Kanno Takeshi, Yasaka Hirohisa, Masu Misuzu, Otomo Masataka, Koike Tomoyuki
Division of Internal Medicine, National Health Insurance Marumori Hospital, Marumori 981-2152, Japan.
Japan National Health Insurance Kuriyama Clinic, Nikko 321-2713, Japan.
Diagnostics (Basel). 2022 Jul 22;12(8):1782. doi: 10.3390/diagnostics12081782.
We aimed to clarify the effectiveness of interventions in outpatients who did not undergo colorectal cancer (CRC) screening. From September 2012 to August 2013, we conducted a project, which showed that the immunological fecal occult blood test (FOBT) was actively recommended for outpatients who were ≥40 years of age, attended the Marumori Hospital regularly, and were not screened for CRC in the previous two years. We evaluated the detection rate of CRC and the disease specific survival ratio in February 2021 among patients with positive FOBT results during the retrospective cohort study. Overall, 388 (91%) out of the 425 outpatients submitted their stool samples. Among 388 outpatients, 66 tested positive for FOBT. While both the positive rate of FOBT and the detection rate of CRC (17% and 0.77%, respectively) were significantly higher than those in the nationwide administrative examination (5.7% and 0.13%, respectively) (p < 0.05), there was no statistically significant difference in the detection rate, compared with the group aged 65 years and older in the nationwide administrative examination. The 7-year CRC-specific survival ratio was 98.5%. Active promotion of FOBT at primary care institutions for outpatients who did not undergo CRC screening may contribute to reducing the frequency of CRC-related deaths.
我们旨在阐明对未接受结直肠癌(CRC)筛查的门诊患者进行干预的效果。2012年9月至2013年8月,我们开展了一个项目,该项目表明,对于年龄≥40岁、定期前往丸森医院就诊且在过去两年内未接受CRC筛查的门诊患者,积极推荐进行免疫粪便潜血试验(FOBT)。在这项回顾性队列研究中,我们评估了2021年2月FOBT结果呈阳性的患者中CRC的检出率和疾病特异性生存率。总体而言,425名门诊患者中有388名(91%)提交了粪便样本。在388名门诊患者中,66名FOBT检测呈阳性。虽然FOBT的阳性率和CRC的检出率(分别为17%和0.77%)均显著高于全国行政检查中的阳性率和检出率(分别为5.7%和0.13%)(p<0.05),但与全国行政检查中65岁及以上年龄组相比,检出率没有统计学上的显著差异。7年CRC特异性生存率为98.5%。在基层医疗机构对未接受CRC筛查的门诊患者积极推广FOBT可能有助于降低CRC相关死亡的发生率。